A prospective study of XELOX plus bevacizumab as first-line therapy in Japanese patients with metastatic colorectal cancer (KSCC 0902)-Reference-Cited by-同舟云学术

A prospective study of XELOX plus bevacizumab as first-line therapy in Japanese patients with metastatic colorectal cancer (KSCC 0902)

Published:2015-09-04 Issue:2 Volume:21 Page:335-343
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Ogata Yutaka, ,Shimokawa Mototsugu,Tanaka Takaho,Emi Yasunori,Oki Eiji,Saeki Hiroshi,Sadanaga Noriaki,Kusumoto Tetsuya,Touyama Tetsuo,Kimura Masami,Baba Hideo,Akagi Yoshito,Shirouzu Kazuo,Maehara Yoshihiko

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10147-015-0895-3.pdf

Reference26 articles.

1. Cancer Statistics in Japan Editorial Board (2013) Cancer statistics in Japan-2013. Foundation for promotion of cancer research. http://ganjoho.jp/en/professional/statistics/brochure/2013_en.html

2. Saltz LB, Cox JV, Blanke C et al (2000) Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med 343:905–914

3. de Gramont A, Figer A, Seymour M et al (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18:2938–2947

4. Hoff PM, Ansari R, Batist G et al (2001) Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. J Clin Oncol 19:2282–2292

5. Van Cutsem E, Twelves C, Cassidy J et al (2001) Xeloda colorectal cancer study group: oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. J Clin Oncol 19:4097–4106

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complete Response of an Iraqi Patient with Multiple Liver Metastasis, Colon Cancer and Deep Vein Thrombosis to XELOX/Bevacizumab Treatment;Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 );2024-09-14

2. Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With RAS Wild-type, Left-Sided Metastatic Colorectal Cancer;JAMA;2023-04-18

3. Systematic Review of Treatments for Colorectal Metastases in Elderly Patients to Guide Surveillance Cessation Following Hepatic Resection for Colorectal Liver Metastases;American Journal of Clinical Oncology;2021-03-11

4. Is there an efficacy-effectiveness gap between randomized controlled trials and real-world studies in colorectal cancer: a systematic review and meta-analysis;Translational Cancer Research;2020-11

5. Comparison of computed tomography imaging analyses for evaluation after chemotherapy in patients with colorectal cancer: a retrospective pooled analysis of six phase II clinical trials;International Journal of Clinical Oncology;2019-07-22